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A B S T R A C T
RNA-binding proteins mediate and control gene expression. As some examples, they regulate pre-mRNA
synthesis and processing; mRNA localisation, translation and decay; and microRNA (miRNA) biogenesis and
function. Here, we present a detailed protocol for RNA pull-down coupled to stable isotope labelling by amino
acids in cell culture (SILAC) mass spectrometry (RP–SMS) that enables quantitative, fast and specific detection of
RNA-binding proteins that regulate miRNA biogenesis. In general, this method allows for the identification of
RNA-protein complexes formed using in vitro or chemically synthesized RNAs and protein extracts derived from
cultured cells.
1. Introduction
miRNAs regulate gene expression and control a variety of biological
processes, including developmental timing, differentiation, metabolism
and neuronal patterning [1–4]. Importantly, a number of miRNAs are
expressed in a tissue-specific manner, thereby contributing to cell dif-
ferentiation and function [5]. Moreover, changes in the levels of a few
miRNAs affect processes that include neural differentiation and the
formation of induced pluripotent stem cells [6,7]. Finally, aberrant
miRNA expression is linked to a variety of human pathological states
including the initiation, progression and metastasis of cancer [8,9].
Mature miRNAs are derived from primary miRNAs (pri-miRNAs) by
nuclear and cytoplasmic processing events [10]. In the nucleus, Drosha
[11] and its RNA-binding partner, DGCR8 [12–15], convert pri-miRNAs
to stem-loop precursor miRNAs (pre-miRNAs) that are exported to the
cytoplasm by Exportin 5 [16]. In the cytoplasm, Dicer cleaves off the
pre-miRNA terminal loop, leaving a miRNA duplex [4,17]. Subse-
quently, one strand of this duplex is incorporated into the RNA-induced
silencing complex (RISC), which binds its target mRNA(s) by imperfect
base-pairing, followed by translational repression and, possibly, dead-
enylation and degradation of the targeted mRNAs [18,19].
We have previously shown that hnRNP A1, a protein implicated in
many aspects of RNA processing, binds to the conserved terminal loop
of pri-miRNA-18a [20,21] and pri-let-7a-1 [22], stimulating and in-
hibiting their processing, respectively. Since then, the biogenesis of
many miRNAs has been shown to be regulated by various RNA-binding
proteins (RBPs) [23,24]. We have elucidated the mechanisms that
regulate miRNA biogenesis in mammalian cells using a method that
combines RNA pull-down with stable isotope labelling by amino acids
in cell culture (SILAC) high-throughput mass spectrometry (which we
call here RP–SMS), developed in our laboratory. We have identified
RBPs that regulate the production of brain-enriched and brain-specific
miRNAs, such as miRNA-7 and miRNA-9 [25–27], as well as factors
responsible for the selective uridylation and degradation of miRNA
precursors in embryonic cells [28]. Here, we describe a step-by-step
RP–SMS protocol that can be used to identify miRNA biogenesis factors
as well as any other RNA-protein complexes.
2. Materials and equipment
2.1. SILAC
- SILAC media, heavy and light (e.g. R6K4 ‘heavy’ and R0K0 ‘light’
(DC Biosciences))
- Dialysed calf serum (DC Biosciences)
- SDS-polyacrylamide gel (we use NuPAGE™ 4–12% Bis-Tris Protein
Gels, Invitrogen, Thermo Fisher Scientific)
- NuPAGE LDS Sample Buffer (Invitrogen)
- NuPAGE Sample Reducing Agent (Invitrogen)
- NuPAGE MOPS SDS Running Buffer (Invitrogen)
- NuPAGE Antioxidant (Invitrogen)
- GelCode Blue Safe protein stain (Thermo Fisher Scientific)
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- Razor blade
- 50mM Ammonium bicarbonate (ABC) (Sigma)
- Acetonitrile (Thermo Fisher Scientific)
- 10mM DTT (Sigma)
- 55mM Iodoacetamide (IAA) (Sigma)
- 20 μg Trypsin glass vial (Thermo Fisher Scientific)
- 0.1% Trifluoroacetic acid (TFA) (Sigma)
- 10% TFA (Sigma)
- Trypsin buffer (Add 20 μl 0.1% TFA to 20 μg trypsin. Mix 100 μl
acetonitrile (final concentration 10%), 200 μl 50mM ABC (final
concentration 10mM) and 700 μl water. Add 3 μl of trypsin solution
to 227 μl acetonitrile/ABC solution to make Trypsin buffer).
- Stage tips C18 (Sigma Supelco)
- Methanol (Fisher Scientific)
- Mass spectrometer
2.2. In vitro transcription
- Primers for your RNA of interest, including a forward primer that
contains the T7 promoter sequence TAATACGACTCACTATAGG
followed by 20 nt of sense DNA template
- High-fidelity PCR kit (such as Phusion polymerase, Thermo Fisher
Scientific)
- PCR machine
- T7 RNA polymerase (such as NxGen T7 RNA Polymerase, Lucigen)
- rNTPs 20mM (Roche)
- RNaseOUT (Invitrogen)
- TURBO DNase (Ambion)
- 3M Sodium acetate (NaOAc) (Fisher Scientific)
- 100% Ethanol (EtOH) (Fisher Scientific)
- 70% EtOH
- Urea loading buffer (ULB) (20mM EDTA, 7M Urea, bromophenol
blue, xylene cyanol)
- 10% polyacrylamide gel (Acrylamide Bis-Acrylamide 19:1, Severn
Biotech) containing 7M Urea (Fisher Scientific)
- 1X Tris/Borate/EDTA (TBE) buffer (To make 5X TBE buffer, dissolve
54 g Tris base and 27.5 g boric acid in approximately 900ml of
deionized water. Add 20ml 0.5M EDTA (pH 8.0), and bring the
final volume to 1 L using deionized water)
- Stains All (Sigma-Aldrich)
- RNA extraction solution (0.3 M NaOAc pH 5.2 (Fisher Scientific),
0.5 mM EDTA (Fisher Scientific), 0.1% w/v SDS (Fisher Scientific))
2.3. RNA pull-down
- In vitro-transcribed and purified RNA (500 pmol)
- Adipic acid dihydrazide-Agarose (Sigma)
- 3M NaOAc pH 5 (Fisher Scientific)
- 0.1 M NaOAc pH 5
- 0.1 M Sodium (meta) periodate (Sigma)
- 100% EtOH
- 70% EtOH
- 4M KCl (Fisher Scientific)
- 2M KCl
- Roeder D buffer (100mM KCl, 20% (v/v) glycerol (Fisher
Scientific), 0.2 mM EDTA (Fisher Scientific), 100mM Tris pH 8.0
(Invitrogen), 0.5 mM DTT (Thermo Fisher Scientific), 0.2 mM PMSF
(Sigma))
- 100mM MgCl2 (VWR)
- 0.5 M Sodium creatine-phosphate dibasic tetrahydrate (CIP) (Sigma)
- 100mM ATP (Sigma)
- RNaseOUT (Invitrogen)
- Buffer G (20mM Tris-HCl pH 7.5, 137mM NaCl (Fisher Scientific),
1 mM EDTA, 1% TritonX-100 (Fisher Scientific), 10% glycerol,
1.5 mM MgCl2 (Fisher Scientific), 1 mM DTT, 0.2mM PMSF
(Thermo Fisher Scientific))
- NuPAGE LDS Sample Buffer (Invitrogen)
- NuPAGE Sample Reducing Agent (Invitrogen)
- SDS-polyacrylamide gel (we use NuPAGE™ 4–12% Bis-Tris Protein
Gels, Invitrogen)
- NuPAGE MOPS SDS Running Buffer (Invitrogen)
- NuPAGE Antioxidant (Invitrogen)
- GelCode Blue Safe protein stain (Thermo Fisher Scientific)
3. Protocol
3.1. Overview
By combining RNA pull-down with SILAC [29] high-throughput
mass spectrometry (RP–SMS) we can identify proteins that bind speci-
fically to a given RNA (such as a pri-miRNA or pre-miRNA), as opposed
to non-specifically to beads [25]. SILAC is a method that detects protein
abundance using the incorporation of non-radioactive ‘heavy’ amino
acid isotopes, which can be distinguished from naturally occurring
‘light’ amino acid isotopes by mass spectrometry. Importantly, we can
also detect RNA-protein complexes derived from different cell types or
the same cell type exposed to different environmental conditions
[26,27]. Finally, using RP–SMS, we can compare two RNAs (e.g. with or
without one or more mutations, or with or without chemical mod-
ification) and uncover differentially bound proteins [28].
The method involves producing cell extracts derived from SILAC-
labelled cells, obtaining RNA (by in vitro transcription or chemical
synthesis), performing the RNA pull-down assay, and undertaking mass
spectrometry analysis.
3.2. SILAC labelling
3.2.1. Incorporate cells with heavy or light isotopes
Grow cells in SILAC media, ‘heavy’ and ‘light’, supplemented with
dialysed calf serum, for six passages. We use DMEM medium containing
13C-labelled arginine and 2D-labelled lysine (R6K4 (DC Biosciences)) as
the heavy SILAC medium, and control DMEM containing unlabelled
arginine and lysine (R0K0 (DC Biosciences)) as the light SILAC medium.
3.2.2. Verify incorporation of heavy isotopes
3.2.2.1. In-gel digestion.
- Electrophorese the protein extract (diluted in 1X NuPAGE LDS
Sample Buffer and 1X NuPAGE Sample Reducing Agent) into an
SDS-polyacrylamide gel using 1X NuPAGE MOPS SDS Running
Buffer supplemented with 1:1000 NuPAGE Antioxidant. Stain the
gel with GelCode Blue.
- Using a razor blade, remove an approximately 0.5-cm piece of gel
from the centre of the protein lane and cut into small pieces that are
approximately 1mm×1mm.
- Transfer the gel pieces to a microfuge tube with 200 μl 50mM ABC
and incubate at room temperature (RT) for 5min. Remove liquid,
add 200 μl acetonitrile, and incubate at RT for 5min. Repeat the
ABC and acetonitrile washes until the solution is no longer blue.
- Add enough 10mM DTT to cover the pieces, using 20–50 μl or more,
and leave at 37 °C for 30min.
- Remove the liquid, and add 200 μl acetonitrile for 5min.
- Turn off the light. Remove the acetonitrile, add 55mM IAA to cover
the gel pieces, and incubate at RT for 20min in the dark. Remove
the IAA, add 50mM ABC for 5min, and then acetonitrile for 5min.
- On ice, prepare Trypsin buffer.
- Add Trypsin buffer to just cover the gel pieces, and incubate on ice
for 15min. As the gel absorbs the buffer, add more Trypsin buffer to
slightly above the gel pieces, and incubate at 37 °C for 30min. Add
enough acetonitrile/ABC solution to slightly above gel pieces (to
make sure the gel pieces do not dry out), and leave at 37 °C over-
night.
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- Add 1:1 vol of 0.1% TFA to samples (e.g. 100 μl), and leave 20min.
Check that the pH is 1–3, or adjust by adding 10% TFA (generally,
0.5 μl of 10% TFA is required).
- Activate a stage tip C18 by pushing or spinning 20 μl methanol
through the tip. Next, condition the tip by pushing or spinning 40 μl
0.1% TFA through the tip.
- Load the sample onto the tip by spinning. Wash by pushing or
spinning 60 μl 0.1% TFA through the tip.
- Maintain the stage tip at −20 °C until ready to load onto a mass
spectrometer.
3.2.2.2. Mass spectrometry.
- Following digestion and peptide purification, perform an LC-MS/MS
analysis using an orbitrap mass spectrometer or a similar machine.
Determine the efficiency of heavy label incorporation into peptides
by manually examining randomly selected peptides from the raw
file. Since arginine and lysine may have different labelling effi-
ciencies, this needs to be done separately for arginine- and lysine-
containing peptides. Arginine-to-proline conversion should also be
examined.
3.3. RNA synthesis
3.3.1. PCR
- Design primers that encompass your RNA of interest, appending a
T7 promoter sequence (TAATACGACTCACTATAGG) to the 5′ end of
the forward primer. Amplify the DNA using high-fidelity PCR, and
confirm the size of the PCR product by electrophoresis in an agarose
gel.
3.3.2. In vitro transcription
- Mix the following in a tube. We use NxGenT7 RNA Polymerase.
DNA 100 μl
10× buffer 25 μl
rNTPs 20mM 12.5 μl
RNaseOUT 5 μl
H20 97.5 μl
T7 RNA polymerase 10 μl
Total 250 μl
- Incubate at 37 °C for 1.5 h.
- Add 1–2 μl TURBO DNase, and incubate at 37 °C for 10min.
- Add 1/10 vol of 3M NaOAc and 3×volume of 100% EtOH, and
precipitate on dry ice for 30min or at −20 °C overnight.
- Precipitate by spinning at 4 °C and full speed for 20min. Wash the
pellet with 70% EtOH, spinning 3min at full speed, and re-suspend
in 40 μl water and 40 μl ULB.
- Boil at 90 °C for 2min, and subsequently cool for 2min on ice.
- Split the sample into two, and electrophorese each half in separate
wells of a pre-run, warm 10% polyacrylamide/urea gel using 1X TBE
as a running buffer.
- Stain with Stains All, and cut out the bands.
- Add 300 μl RNA extraction solution, and leave on the bench over-
night.
- Next day, transfer the supernatant to a new tube, and add 900 μl
100% EtOH. Incubate at −20 °C over-night, or on dry ice for 1 h.
- Spin at full speed for 20min to precipitate the RNA, and wash the
resulting RNA pellet with 70% EtOH.
3.4. RNA pull-down
3.4.1. Coupling of RNA to agarose beads
- Prepare the following mix in a total volume of 200 μl:
RNA 500 pmol
NaOAc 6.7 μl 3 M NaOAc pH 5 (final concentration
100mM)
Sodium (meta)
periodate
10 μl 0.1M (final concentration 5mM)
H20 to 200 μl
- Wrap all tubes in foil to protect from light. Leave rotating on a wheel
at RT for 1 h.
- Precipitate the RNA by adding 15 μl 3 M NaOAc and 600 μl 100%
EtOH, and leave on dry ice for 10–30min. Spin at 4 °C and full speed
for 20min. Wash with 1ml 70% EtOH, and spin at 4 °C and full
speed for 3min. Re-suspend the RNA in 500 μl 100mM NaOAc pH 5.
- Transfer 250 μl Adipic acid dihydrazide-Agarose resin (50%) per
reaction to a 15ml tube using a cut pipette tip, and wash 3 times
with 10ml 100mM NaOAc, spinning 300 rpm for 3min after each
wash. Re-suspend the final pellet in enough 100mM NaOAc to have
a mix of 50% beads/liquid. You will need 200 μl mix per reaction.
Add 200 μl beads to the 500 μl periodate-treated RNA, and leave
rocking at 4 °C overnight.
- Remove the foil. Add 700 μl 4 M KCl to the mix, and rock at RT for
30min. Pellet the resin at 3000 rpm for 3min, discarding the su-
pernatant. Wash the resin twice with 1ml 2M KCl, and 3 times with
Roeder D buffer, spinning at 300 rpm for 2min after each wash.
3.4.2. Incubate RNA-beads with protein extracts
Add to the pelleted resins:
Extract 250 μl (1–1.5mg total protein, add Roeder D buffer if
using less protein)
MgCl2 9.75 μl 100mM (1.5 mM)
CIP 32.5 μl 0.5M (25mM)
ATP 3.25 μl 100mM (0.5 mM)
RNaseOUT 5 μl
H20 349.5 μl
Total 650 μl
- Incubate at 37 °C for 30min with rocking at 400 rpm. Pellet by
spinning at 1000 rpm for 3min. Save the supernatant as a loading
control.
3.4.3. Wash away unbound protein
- Work on ice. Wash reactions three times with 1ml Buffer G, spin-
ning at 4 °C and 1000 rpm for 2min. Combine the “light” and
“heavy” samples during the last wash.
3.4.4. Electrophorese proteins into a SDS-PAGE gel
- To the beads add: 39 μl H2O, 15 μl NuPAGE LDS Sample Buffer, and
6 μl NuPAGE Sample Reducing Agent.
- Boil at 70 °C for 10min while shaking. Spin at RT and full speed for
one min, and load 30 μl.
- Electrophorese the sample into an SDS-polyacrylamide gel using 1X
NuPAGE MOPS SDS Running Buffer supplemented with 1:1000
NuPAGE Antioxidant, so that the dye migrates 1 cm into the gel.
Stain the gel with GelCode Blue Safe protein stain.
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3.5. Mass spectrometry analysis
- Cut out the band, proceed with in-gel digestion as described in
Section 3.2.2, and perform an LC-MS/MS analysis using an orbitrap
mass spectrometer or its equivalent. The MaxQuant software [30]
platform is used to analyse the raw mass-spectrometry data in order
to determine the ratio of the heavy-labelled peptides to the light-
labelled peptides. The samples can also be analysed by Western
blotting for known proteins.
4. Results
We developed the RP–SMS method to identify proteins that bind to
the let-7a-1 pre-miRNA (pre-let-7a-1). Pre-let-7a-1 is known to be
regulated by LIN28A [31–33], hnRNP A1 [20,22] and KSRP [34]. To
determine what protein factors bind specifically to pre-let-7a-1, as op-
posed to non-specifically to agarose beads, we compared the beads
alone incubated with ‘light’ HeLa-cell extract to pre-let-7a-1-coupled
beads incubated with ‘heavy’ HeLa-cell extract.
We incorporated R6K4 into HeLa cells constitutively expressing
LIN28A, and confirmed the SILAC incorporation (Fig. 1). Protein ex-
tracts from ‘heavy’ (H) and ‘light’ (L) cells were generated by scraping
adherent cells in Roeder D buffer, followed by cell lysis using sonica-
tion, and clearing the extracts using centrifugation. The RP-SMS pro-
tocol was followed for the pre-let-7a-1 as described above, providing us
with a list of identified proteins and their H/L ratios, peptide counts and
intensities, and many additional features (Supplementary Table 1).
Notably, a H/L ratio of 1 in the RNA pull-down compared to the
beads-only control signifies that there is no enrichment of protein
binding to RNA. H/L ratios of≤0.5 indicate either preferential cellular
protein binding to the beads-only control or protein contaminants that
derive from the environment (such as the experimentalist’s skin). H/L
ratios of ≥2 indicate specific protein binding to the RNA.
H/L ratios revealed that 81 cellular proteins were enriched at least
two-fold (H/L ratio ≥2) in the pre-let-7a-1 pull-down compared to the
beads-only control (Fig. 2), among which were many known RNA-
binding proteins, such as the helicase DHX9, several hnRNP proteins,
LIN28A, the splicing factor SRSF1, and the novel RNA-binding protein
TRIM25 (Supplementary Table 1). In contrast, the ratio observed for
828 other proteins was> 0.5 and<2 when binding to RNA vs. binding
to the beads-only control were compared, indicating non-specific
binding. Of the 19 proteins enriched on beads alone (H/L ratio ≤0.5),
there were several types of keratin (a common mass spectrometry
contaminant).
To validate the specificity of our RNA pull-down assay, we in-
troduced a well-known LIN28A-binding site (GGAG) into the terminal
loop of pre-miR-16, which does not bind LIN28A (Fig. 3A)
[27,28,33,35]. All pre-miRNA-16 mutants showed efficient LIN28A
binding (Fig. 3B). DHX9, which recognises double-stranded RNA, also
displayed binding to all pre-miRNA-16 transcripts (Fig. 3B). Finally, we
introduced hnRNP A1-binding sites (UAGG) [20,35] into pri-miR-16
and showed that all mutants with UAGG sequences bind hnRNP A1
efficiently (Fig. 3B). It is important to note that introducing binding
sites for miRNA biogenesis factors does not automatically mean that
processing of the pri-miRNAs or pre-miRNAs is dependent on or regu-
lated by these factors. Other sequences, structural elements, and protein
factors cooperate to control the miRNA processing pathway.
As the next step towards identifying miRNA processing factors, one
could take all significant hits from the RP–SMS experiment and perform
loss-of-function (RNAi and/or CRISPR/Cas9) or gain-of-function (over-
expression) experiments. This should be followed by in vitro processing
assays and/or in vivo miRNA processing analysis using extracts from
Fig. 1. An example of an MS1 spectrum in which the incorporation of heavy arginine is displayed. A peptide with a heavy-labelled arginine is highlighted in red. The
absence of the corresponding non-labelled arginine-containing peptide (highlighted in blue) confirms full SILAC incorporation. (For interpretation of the references
to colour in this figure legend, the reader is referred to the web version of this article.)
Fig. 2. Distribution of H/L ratios among proteins identified in the pre-let-7a-1
pull-down. We used the RP–SMS method to identify protein factors that bind
specifically to pre-let-7a-1 (H) or non-specifically to beads alone (L). Results
reveal that although most proteins identified do not bind specifically to pre-let-
7a-1 (i.e., they have H/L ratio of less than 2), 81 proteins are enriched 2-fold or
more in the pre-let-7a-1 pull-down.
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wild-type, candidate factor-depleted, or candidate factor-over-
expressing cells.
5. Concluding remarks
The regulation of RNA processing by RBPs is at the functional heart
of all cells. RBPs mediate and control gene expression by regulating
virtually all steps of RNA metabolism [36,37]. Consequently, they
contribute to cellular homeostasis, development and disease. Further-
more, hundreds of novel RBPs have been recently identified [38–41].
Many of these proteins have not been previously known for their RNA-
binding properties and do not contain canonical RNA-binding domains.
This highlights the need for methods that detect physiologically re-
levant RNA-protein complexes.
Many methods to identify protein binding to specific RNAs have
recently been established [42]. We have previously developed a method
based on RNA-coupled agarose beads and RNase-assisted elution of
RBPs [43]. Furthermore, high-throughput screens for regulators of
miRNA processing have revealed numerous sequence-specific factors
that bind to miRNA precursors and primary transcripts [24,35,44]. The
RNA pull-down combined with SILAC high-throughput mass spectro-
metry (RP–SMS) protocol described in this paper allows for versatile
experimental design and high levels of sequence specificity for the
quantitative detection of RBPs.
Acknowledgements
We would like to thank Christos Spanos and Juri Rappsilber for their
help with mass spectrometry. We would like to thank Gregory Heikel
for critical reading of the manuscript.
Funding sources
G.M. was a recipient of an MRC Career Development Award
(G10000564). This work was also supported by two Wellcome Trust
Centre CORE Grants (077707 and 092076) and by a Wellcome Trust
Instrument Grant (091020). The authors declare that they have no
conflict of interest.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in the
online version, at http://dx.doi.org/10.1016/j.ymeth.2018.06.006.
References
[1] Y. Shi, X. Zhao, J. Hsieh, H. Wichterle, S. Impey, S. Banerjee, P. Neveu, K.S. Kosik,
MicroRNA regulation of neural stem cells and neurogenesis, J. Neurosci. 30 (45)
(2010) 14931–14936.
[2] A. Pauli, J.L. Rinn, A.F. Schier, Non-coding RNAs as regulators of embryogenesis,
Nat. Rev. Genet. 12 (2) (2011) 136–149.
[3] R.C. Lee, V. Ambros, An extensive class of small RNAs in caenorhabditis elegans,
pre-miR-16           UAGCAGCACGUAAAUAUUGGCGUUAAGAUUCUAAAAUUAUCUCCAGUAUUAACUGUGCUGCUGA
pre-miR-16_GGAG@4    UAGCAGCACGUAAAUAUUGGCGUUAAGAUUCUAAGGAGAUCUCCAGUAUUAACUGUGCUGCUGA
pre-miR-16_UAGGAG@4  UAGCAGCACGUAAAUAUUGGCGUUAAGAUUCUUAGGAGAUCUCCAGUAUUAACUGUGCUGCUGA
pre-miR-16_GGAGUA@4  UAGCAGCACGUAAAUAUUGGCGUUAAGAUUCUAAGGAGUACUCCAGUAUUAACUGUGCUGCUGA
pre-miR-16_GGAG@5    UAGCAGCACGUAAAUAUUGGCGUUAAGAUUCUAGGAGUAUCUCCAGUAUUAACUGUGCUGCUGA
pre-miR-16_AUGGAG@5  UAGCAGCACGUAAAUAUUGGCGUUAAGAUUCAUGGAGUAUCUCCAGUAUUAACUGUGCUGCUGA
pre-miR-16_GGAGAU@5  UAGCAGCACGUAAAUAUUGGCGUUAAGAUUCUAGGAGAUUCUCCAGUAUUAACUGUGCUGCUGA
hnRNPA1     LIN28A
binding
+
+
+
+
+
+
+
+
+
-
-
-
-
-
A
pr
e-
mi
R-
16
pr
e-
mi
R-
16
_G
GA
G@
4
pr
e-
mi
R-
16
_U
AG
GA
G@
4
pr
e-
mi
R-
16
_G
GA
GU
A@
4
pr
e-
mi
R-
16
_G
GA
G@
5
pr
e-
mi
R-
16
_A
UG
GA
G@
5
pr
e-
mi
R-
16
_G
GA
GA
U@
5
be
ad
s
loa
dn
ig 
co
ntr
ol 
P1
9 d
0
WB: LIN28A
WB: hnRNP A1
B
WB: DHX9
Fig. 3. Introduction of LIN28A- or hnRNAP A1-binding sites into pre-miR-16 validates the specificity of the RNA pull-down. (a) A LIN28A-binding site (GGAG) and/
or an hnRNP A1-binding site (UAGG) was introduced into pre-miR-16. In set @4, AAUU was changed to GGAG, whereas in set @5, AAAU was changed to GGAG. Pre-
miR-16_UAGGAG@4, pre-miR-16_GGAG@5 and pre-miR-16-GGAGAU@5 were engineered to harbor a hnRNP A1 UAGG binding site. Green letters indicate in-
troduced GGAG binding sites. Red letters mark A-to-U or U-to-A substitutions, which either test for the specificity of RNA pull-down, or, in case of pre-miR-
16_UAGGAG@4, introduce an hnRNP A1-binding site. b) RNA pull-down and Western blotting were performed. Western blotting probed for LIN28A, hnRNAP A1, or
DHX9. Results showed that only the pre-miR-16 mutants that contain a LIN28A-binding site bind LIN28A, and only those mutants that contain an hnRNP A1-binding
site bind hnRNP A1. All pre-miR-16 mutants bind DHX9, which binds any double-stranded RNA. (For interpretation of the references to colour in this figure legend,
the reader is referred to the web version of this article.)
N.R. Choudhury, G. Michlewski Methods xxx (xxxx) xxx–xxx
5
Science 294 (5543) (2001) 862–864.
[4] R.F. Ketting, S.E. Fischer, E. Bernstein, T. Sijen, G.J. Hannon, R.H. Plasterk, Dicer
functions in RNA interference and in synthesis of small RNA involved in develop-
mental timing in C. elegans, Genes Dev. 15 (20) (2001) 2654–2659.
[5] P. Landgraf, M. Rusu, R. Sheridan, A. Sewer, N. Iovino, A. Aravin, S. Pfeffer, A. Rice,
A.O. Kamphorst, M. Landthaler, C. Lin, N.D. Socci, L. Hermida, V. Fulci, S. Chiaretti,
R. Foa, J. Schliwka, U. Fuchs, A. Novosel, R.U. Muller, B. Schermer, U. Bissels,
J. Inman, Q. Phan, M. Chien, D.B. Weir, R. Choksi, G. De Vita, D. Frezzetti,
H.I. Trompeter, V. Hornung, G. Teng, G. Hartmann, M. Palkovits, R. Di Lauro,
P. Wernet, G. Macino, C.E. Rogler, J.W. Nagle, J. Ju, F.N. Papavasiliou, T. Benzing,
P. Lichter, W. Tam, M.J. Brownstein, A. Bosio, A. Borkhardt, J.J. Russo, C. Sander,
M. Zavolan, T. Tuschl, A mammalian microRNA expression atlas based on small
RNA library sequencing, Cell 129 (7) (2007) 1401–1414.
[6] A.S. Yoo, A.X. Sun, L. Li, A. Shcheglovitov, T. Portmann, Y. Li, C. Lee-Messer,
R.E. Dolmetsch, R.W. Tsien, G.R. Crabtree, MicroRNA-mediated conversion of
human fibroblasts to neurons, Nature 476 (7359) (2011) 228–231.
[7] R.L. Judson, J.E. Babiarz, M. Venere, R. Blelloch, Embryonic stem cell-specific
microRNAs promote induced pluripotency, Nat. Biotechnol. 27 (5) (2009) 459–461.
[8] A. Ventura, T. Jacks, MicroRNAs and cancer: short RNAs go a long way, Cell 136 (4)
(2009) 586–591.
[9] M.V. Iorio, C.M. Croce, MicroRNA dysregulation in cancer: diagnostics, monitoring
and therapeutics. A comprehensive review, EMBO Mol Med. 4 (3) (2012) 143–159.
[10] M. Ha, V.N. Kim, Regulation of microRNA biogenesis, Nat. Rev. Mol. Cell Biol. 15
(8) (2014) 509–524.
[11] Y. Lee, C. Ahn, J. Han, H. Choi, J. Kim, J. Yim, J. Lee, P. Provost, O. Radmark,
S. Kim, V.N. Kim, The nuclear RNase III Drosha initiates microRNA processing,
Nature 425 (6956) (2003) 415–419.
[12] A.M. Denli, B.B. Tops, R.H. Plasterk, R.F. Ketting, G.J. Hannon, Processing of pri-
mary microRNAs by the microprocessor complex, Nature 432 (7014) (2004)
231–235.
[13] R.I. Gregory, K.P. Yan, G. Amuthan, T. Chendrimada, B. Doratotaj, N. Cooch,
R. Shiekhattar, The Microprocessor complex mediates the genesis of microRNAs,
Nature 432 (7014) (2004) 235–240.
[14] J. Han, Y. Lee, K.H. Yeom, Y.K. Kim, H. Jin, V.N. Kim, The Drosha-DGCR8 complex
in primary microRNA processing, Genes Dev. 18 (24) (2004) 3016–3027.
[15] M. Landthaler, A. Yalcin, T. Tuschl, The human DiGeorge syndrome critical region
gene 8 and Its D. melanogaster homolog are required for miRNA biogenesis, Curr.
Biol. 14 (23) (2004) 2162–2167.
[16] V.N. Kim, MicroRNA precursors in motion: exportin-5 mediates their nuclear ex-
port, Trends Cell Biol. 14 (4) (2004) 156–159.
[17] G. Hutvagner, J. McLachlan, A.E. Pasquinelli, E. Balint, T. Tuschl, P.D. Zamore, A
cellular function for the RNA-interference enzyme Dicer in the maturation of the
let-7 small temporal RNA, Science 293 (5531) (2001) 834–838.
[18] M.R. Fabian, N. Sonenberg, W. Filipowicz, Regulation of mRNA translation and
stability by microRNAs, Annu. Rev. Biochem. 79 (2010) 351–379.
[19] E. Izaurralde, Elucidating the temporal order of silencing, EMBO Rep. 13 (8) (2012)
662–663.
[20] G. Michlewski, S. Guil, C.A. Semple, J.F. Caceres, Posttranscriptional regulation of
miRNAs harboring conserved terminal loops, Mol Cell 32 (3) (2008) 383–393.
[21] G. Michlewski, S. Guil, J.F. Caceres, Stimulation of pri-miR-18a processing by
hnRNP A1, Adv. Exp. Med. Biol. 700 (2011) 28–35.
[22] G. Michlewski, J.F. Caceres, Antagonistic role of hnRNP A1 and KSRP in the reg-
ulation of let-7a biogenesis, Nat. Struct. Mol. Biol. 17 (8) (2010) 1011–1018.
[23] J. Krol, I. Loedige, W. Filipowicz, The widespread regulation of microRNA bio-
genesis, function and decay, Nat. Rev. Genet. 11 (9) (2010) 597–610.
[24] T. Treiber, N. Treiber, U. Plessmann, S. Harlander, J.L. Daiss, N. Eichner,
G. Lehmann, K. Schall, H. Urlaub, G. Meister, A Compendium of RNA-binding
proteins that regulate microRNA biogenesis, Mol. Cell 66 (2) (2017) 270–284e13.
[25] N.R. Choudhury, F. de Lima Alves, L. de Andres-Aguayo, T. Graf, J.F. Caceres,
J. Rappsilber, G. Michlewski, Tissue-specific control of brain-enriched miR-7 bio-
genesis, Genes Dev. 27 (1) (2013) 24–38.
[26] J.S. Nowak, N.R. Choudhury, F. de Lima Alves, J. Rappsilber, G. Michlewski, Lin28a
regulates neuronal differentiation and controls miR-9 production, Nat. Commun. 5
(2014) 3687.
[27] J.S. Nowak, F. Hobor, A. Downie Ruiz Velasco, N.R. Choudhury, G. Heikel, A. Kerr,
A. Ramos, G. Michlewski, Lin28a uses distinct mechanisms of binding to RNA and
affects miRNA levels positively and negatively, RNA 23 (3) (2017) 317–332.
[28] N.R. Choudhury, J.S. Nowak, J. Zuo, J. Rappsilber, S.H. Spoel, G. Michlewski,
Trim25 is an RNA-specific activator of Lin28a/TuT4-mediated uridylation, Cell
Rep. 9 (4) (2014) 1265–1272.
[29] S.E. Ong, B. Blagoev, I. Kratchmarova, D.B. Kristensen, H. Steen, A. Pandey,
M. Mann, Stable isotope labeling by amino acids in cell culture, SILAC, as a simple
and accurate approach to expression proteomics, Mol Cell Proteom. 1 (5) (2002)
376–386.
[30] J. Cox, M. Mann, MaxQuant enables high peptide identification rates, in-
dividualized p.p.b.-range mass accuracies and proteome-wide protein quantifica-
tion, Nat. Biotechnol. 26 (12) (2008 Dec) 1367–1372, http://dx.doi.org/10.1038/
nbt.1511.
[31] S.R. Viswanathan, G.Q. Daley, R.I. Gregory, Selective blockade of microRNA pro-
cessing by Lin28, Science 320 (5872) (2008) 97–100.
[32] J.P. Hagan, E. Piskounova, R.I. Gregory, Lin28 recruits the TUTase Zcchc11 to in-
hibit let-7 maturation in mouse embryonic stem cells, Nat. Struct. Mol. Biol. 16 (10)
(2009) 1021–1025.
[33] I. Heo, C. Joo, Y.K. Kim, M. Ha, M.J. Yoon, J. Cho, K.H. Yeom, J. Han, V.N. Kim,
TUT4 in concert with Lin28 suppresses microRNA biogenesis through pre-
microRNA uridylation, Cell 138 (4) (2009) 696–708.
[34] M. Trabucchi, P. Briata, M. Garcia-Mayoral, A.D. Haase, W. Filipowicz, A. Ramos,
R. Gherzi, M.G. Rosenfeld, The RNA-binding protein KSRP promotes the biogenesis
of a subset of microRNAs, Nature 459 (7249) (2009) 1010–1014.
[35] H. Towbin, P. Wenter, B. Guennewig, J. Imig, J.A. Zagalak, A.P. Gerber, J. Hall,
Systematic screens of proteins binding to synthetic microRNA precursors, Nucleic
Acids Res. 41 (3) (2013) e47.
[36] A. Eulalio, I. Behm-Ansmant, E. Izaurralde, P bodies: at the crossroads of post-
transcriptional pathways, Nat. Rev. Mol. Cell Biol. 8 (1) (2007) 9–22.
[37] T. Glisovic, J.L. Bachorik, J. Yong, G. Dreyfuss, RNA-binding proteins and post-
transcriptional gene regulation, FEBS Lett. 582 (14) (2008) 1977–1986.
[38] A. Castello, B. Fischer, K. Eichelbaum, R. Horos, B.M. Beckmann, C. Strein,
N.E. Davey, D.T. Humphreys, T. Preiss, L.M. Steinmetz, J. Krijgsveld, M.W. Hentze,
Insights into RNA biology from an atlas of mammalian mRNA-binding proteins, Cell
149 (6) (2012) 1393–1406.
[39] A.G. Baltz, M. Munschauer, B. Schwanhausser, A. Vasile, Y. Murakawa, M. Schueler,
N. Youngs, D. Penfold-Brown, K. Drew, M. Milek, E. Wyler, R. Bonneau, M. Selbach,
C. Dieterich, M. Landthaler, The mRNA-bound proteome and its global occupancy
profile on protein-coding transcripts, Mol. Cell 46 (5) (2012) 674–690.
[40] S.C. Kwon, H. Yi, K. Eichelbaum, S. Fohr, B. Fischer, K.T. You, A. Castello,
J. Krijgsveld, M.W. Hentze, V.N. Kim, The RNA-binding protein repertoire of em-
bryonic stem cells, Nat. Struct. Mol. Biol. 20 (9) (2013) 1122–1130.
[41] Y. Liao, A. Castello, B. Fischer, S. Leicht, S. Foehr, C.K. Frese, C. Ragan,
S. Kurscheid, E. Pagler, H. Yang, J. Krijgsveld, M.W. Hentze, T. Preiss, The cardi-
omyocyte RNA-binding proteome: links to intermediary metabolism and heart
disease, Cell Rep. 16 (5) (2016) 1456–1469.
[42] C. Faoro, S.F. Ataide, Ribonomic approaches to study the RNA-binding proteome,
FEBS Lett. 588 (20) (2014) 3649–3664.
[43] G. Michlewski, J.F. Caceres, RNase-assisted RNA chromatography, RNA 16 (8)
(2010) 1673–1678.
[44] J.K. Nussbacher, G.W. Yeo, Systematic discovery of RNA binding proteins that
regulate microRNA levels, Mol. Cell 69 (6) (2018) 1005–1016 e7.
N.R. Choudhury, G. Michlewski Methods xxx (xxxx) xxx–xxx
6
